TR200102729T2 - Platelet yapışmasını bloke etme amaçlı protein - Google Patents
Platelet yapışmasını bloke etme amaçlı proteinInfo
- Publication number
- TR200102729T2 TR200102729T2 TR2001/02729T TR200102729T TR200102729T2 TR 200102729 T2 TR200102729 T2 TR 200102729T2 TR 2001/02729 T TR2001/02729 T TR 2001/02729T TR 200102729 T TR200102729 T TR 200102729T TR 200102729 T2 TR200102729 T2 TR 200102729T2
- Authority
- TR
- Turkey
- Prior art keywords
- protein
- collagen
- cells
- platelet adhesion
- naturally occurring
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
Tibbi sülük Hirudo medicinalis'in tükürügünden izole edilen, dogal yoldan olusan ve güçlü sekilde kolajene baglanan ve böylelikle kalojene dogal platelet yapismasini önleyici olarak hareket eden protein tarif edilir.Protein, yaklasik 12000 moleküler agirliga, bir asidik izoelektrik noktaya sahiptir ve alti sistein içerir. Protein sekanslandi ve gen, H.medicinalis cDNA-kütüphanesinden klonlandi. Yeniden birlestirici tekniklerle böyle polipeptidin üretilmesi prosedürü açiklanir. Yeniden birlestirici ve dogal yoldan olusan proteinler, kolajene bagimli platelet yapismasinin güçlü önleyicileridir ve bu nedenle kalp hastaliklari ve dolasim sistemi hastaliklariyla ilgili çesitli durumlarin terapötik tedavisinde yararlidirlar. Ayrica protein, dogal veya suni kolajen yüzeylerin hücreler için yapiskan olmamalarini saglamak ve hücrelerin aktiflestirlmesini önlemek amaciyla bu yüzeylerin kaplanmasinda yaralidir.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99105530 | 1999-03-18 | ||
EP99109503 | 1999-05-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200102729T2 true TR200102729T2 (tr) | 2002-04-22 |
Family
ID=26152935
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2001/02729T TR200102729T2 (tr) | 1999-03-18 | 2000-03-10 | Platelet yapışmasını bloke etme amaçlı protein |
Country Status (27)
Country | Link |
---|---|
US (3) | US6774107B1 (tr) |
EP (1) | EP1161530B1 (tr) |
JP (1) | JP4805461B2 (tr) |
KR (1) | KR100788219B1 (tr) |
CN (1) | CN1185344C (tr) |
AR (1) | AR023099A1 (tr) |
AT (1) | ATE295883T1 (tr) |
AU (1) | AU767172B2 (tr) |
BR (1) | BR0009074A (tr) |
CA (1) | CA2367457C (tr) |
CO (1) | CO5241328A1 (tr) |
CZ (1) | CZ301524B6 (tr) |
DE (1) | DE60020220T2 (tr) |
DK (1) | DK1161530T3 (tr) |
ES (1) | ES2240067T3 (tr) |
HK (1) | HK1045330B (tr) |
HU (1) | HU228068B1 (tr) |
MX (1) | MXPA01009363A (tr) |
MY (1) | MY123371A (tr) |
NO (1) | NO330769B1 (tr) |
PL (1) | PL200384B1 (tr) |
PT (1) | PT1161530E (tr) |
RU (1) | RU2292351C2 (tr) |
SI (1) | SI1161530T1 (tr) |
SK (1) | SK287496B6 (tr) |
TR (1) | TR200102729T2 (tr) |
WO (1) | WO2000056885A1 (tr) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6774107B1 (en) * | 1999-03-18 | 2004-08-10 | Merck Patent Gmbh | Protein for blocking platelet adhesion |
MY128992A (en) * | 2000-08-25 | 2007-03-30 | Merck Patent Gmbh | Saratin for inhibiting platelet adhesion to collagen |
JP2005511005A (ja) * | 2001-07-18 | 2005-04-28 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング | 糖タンパク質vi融合タンパク質 |
WO2005042043A2 (en) | 2003-10-28 | 2005-05-12 | Medtronic, Inc. | Methods of preparing crosslinked materials and bioprosthetic devices |
US8017634B2 (en) | 2003-12-29 | 2011-09-13 | President And Fellows Of Harvard College | Compositions for treating obesity and insulin resistance disorders |
KR101340580B1 (ko) * | 2004-10-12 | 2013-12-11 | 보드 오브 트러스티즈 오브 미시건 스테이트 유니버시티 | 플로로글루시놀의 생합성 및 이로부터1,3-디하이드록시벤젠의 합성 |
CA2611102A1 (en) * | 2005-05-26 | 2006-11-30 | Thomas Jefferson University | Method to treat and prevent posterior capsule opacification |
CA2623565A1 (en) * | 2005-09-28 | 2007-04-05 | Biovascular, Inc. | Methods and compositions for blocking platelet and cell adhesion, cell migration and inflammation |
US20110034396A1 (en) * | 2005-09-28 | 2011-02-10 | Biovascular, Inc. | Methods and compositions for inhibiting cell migration and treatment of inflammatory conditions |
US20080015145A1 (en) * | 2006-07-11 | 2008-01-17 | Maria Gyongyossy-Issa | Mimotope receptors and inhibitors for platelet-platelet and platelet-endothelium interactions |
GB2460915B (en) | 2008-06-16 | 2011-05-25 | Biovascular Inc | Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor |
AU2009305636A1 (en) | 2008-10-15 | 2010-04-22 | Ionis Pharmaceuticals, Inc. | Modulation of Factor 11 expression |
WO2012003461A2 (en) | 2010-07-02 | 2012-01-05 | Draths Corporation | Phloroglucinol synthases and methods of making and using the same |
WO2012006244A1 (en) | 2010-07-06 | 2012-01-12 | Draths Corporation | Method for producing phloroglucinol and dihydrophloroglucinol |
WO2012006245A1 (en) | 2010-07-06 | 2012-01-12 | Draths Corporation | Phloroglucinol reductase and methods of making and using the same |
PL3333188T3 (pl) | 2010-08-19 | 2022-05-09 | Zoetis Belgium S.A. | Przeciwciała anty-ngf i ich zastosowanie |
US8790651B2 (en) | 2011-07-21 | 2014-07-29 | Zoetis Llc | Interleukin-31 monoclonal antibody |
DE202012012998U1 (de) | 2011-08-31 | 2014-06-13 | Daniel Elias | Bioaktive, regenerative Mischung zur Herstellung eines Ergänzungsnahrungsmittels |
JP6629069B2 (ja) | 2012-06-06 | 2020-01-15 | ゾエティス・エルエルシー | イヌ化抗ngf抗体およびその方法 |
US20150190499A1 (en) | 2012-07-19 | 2015-07-09 | Zoetis Llc | Bovine influenza c virus compositions |
AU2013295770A1 (en) | 2012-07-27 | 2015-01-29 | Zoetis Services Llc | Tick toxin compositions |
CA3033759C (en) | 2016-08-17 | 2022-06-14 | Pharmaq As | Sea lice vaccine |
BR102017005783A2 (pt) * | 2017-03-21 | 2018-10-02 | Fund Butantan | processo de obtenção de esculptina e seus fragmentos, esculptina recombinante e seus usos |
EP3765499A1 (en) | 2018-03-12 | 2021-01-20 | Zoetis Services LLC | Anti-ngf antibodies and methods thereof |
MA52011A (fr) | 2018-03-16 | 2021-01-20 | Zoetis Services Llc | Vaccins peptidiques contre l'interleukine-31 |
KR20230145511A (ko) | 2018-03-16 | 2023-10-17 | 조에티스 서비시즈 엘엘씨 | 수의학적 용도를 위한 인터류킨-31 단클론성 항체 |
BR112020020957B1 (pt) | 2018-05-09 | 2022-05-10 | Ionis Pharmaceuticals, Inc | Compostos oligoméricos, população e composição farmacêutica dos mesmos e seus usos |
CN114616325A (zh) | 2019-09-11 | 2022-06-10 | 硕腾服务有限责任公司 | 表达禽病原体抗原的重组火鸡疱疹病毒载体和其用途 |
US20220119513A1 (en) | 2020-06-08 | 2022-04-21 | Zoetis Services Llc | Anti-tgfb antibodies and therapeutic uses thereof |
US20210386854A1 (en) | 2020-06-15 | 2021-12-16 | Zoetis Services Llc | Cell Line for Production of Marek's Disease Virus Vaccine and Methods of Making and Using the Same |
CA3198362A1 (en) | 2020-10-07 | 2022-04-14 | Zoetis Services Llc | Anti-ngf antibodies and methods of use thereof |
TW202221039A (zh) | 2020-10-19 | 2022-06-01 | 美商碩騰服務公司 | 犬及貓抑瘤素M受體β之抗體及其用途 |
WO2023049917A1 (en) | 2021-09-27 | 2023-03-30 | Zoetis Services Llc | ANTI- TGFβ1,2,3 ANTIBODIES AND THERAPEUTIC USES THEREOF |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5705355A (en) * | 1984-03-27 | 1998-01-06 | Transgene, S.A. | Hirudin, pharmaceutical compositions comprising it and their use |
US4898734A (en) | 1988-02-29 | 1990-02-06 | Massachusetts Institute Of Technology | Polymer composite for controlled release or membrane formation |
IL86857A (en) * | 1988-06-24 | 1994-04-12 | Yissum Res Dev Co | Platelet-aggregating inhibitory agents from leech saliva and pharmaceutical preparations containing the same |
US5182260A (en) * | 1989-01-27 | 1993-01-26 | Biogen, Inc. | Dna sequences encoding snake venom inhibitors of platelet activation processes for producing those inhibitors and compositions using them |
CA2052486A1 (en) * | 1990-10-09 | 1992-04-10 | Thomas M. Connolly | Protein for inhibiting collagen-stimulated platelet aggregation |
GB9022040D0 (en) * | 1990-10-10 | 1990-11-21 | Biopharm Ltd | Platelet adhesion inhibitor |
DE4136513A1 (de) * | 1991-11-06 | 1993-05-13 | Basf Ag | Neues thrombininhibitorisches protein aus raubwanzen |
SK282961B6 (sk) * | 1993-07-01 | 2003-01-09 | Merck Patent Gesellschaft Mit Beschr�Nkter Haftung | Purifikovaný proteín, spôsob jeho výroby a použitia a farmaceutický prostriedok na jeho báze |
DE69434598T3 (de) | 1993-07-29 | 2010-07-29 | The United States Of America Represented By The Secretary, Department Of Health And Human Services | Verwendung von Paclitaxel und seinen Derivaten zur Herstellung eines Medikaments für die Behandlung von Restenose |
RO117971B1 (ro) * | 1994-09-12 | 2002-11-29 | Schering Ag | Procedeu de obtinere a unei proteine asp pallidipin recombinanta, proteina obtinuta si compozitie farmaceutica cu aceasta |
ATE211765T1 (de) * | 1994-10-28 | 2002-01-15 | Vitaleech Bioscience N V | Neue familie von proteaseinhibitoren und andere biologisch aktive substanzen |
US6774107B1 (en) * | 1999-03-18 | 2004-08-10 | Merck Patent Gmbh | Protein for blocking platelet adhesion |
MY128992A (en) * | 2000-08-25 | 2007-03-30 | Merck Patent Gmbh | Saratin for inhibiting platelet adhesion to collagen |
-
2000
- 2000-03-10 US US09/936,737 patent/US6774107B1/en not_active Expired - Fee Related
- 2000-03-10 RU RU2001126921/13A patent/RU2292351C2/ru not_active IP Right Cessation
- 2000-03-10 HU HU0200353A patent/HU228068B1/hu not_active IP Right Cessation
- 2000-03-10 JP JP2000606744A patent/JP4805461B2/ja not_active Expired - Fee Related
- 2000-03-10 CA CA2367457A patent/CA2367457C/en not_active Expired - Fee Related
- 2000-03-10 TR TR2001/02729T patent/TR200102729T2/tr unknown
- 2000-03-10 KR KR1020017011881A patent/KR100788219B1/ko not_active IP Right Cessation
- 2000-03-10 SK SK1290-2001A patent/SK287496B6/sk not_active IP Right Cessation
- 2000-03-10 BR BR0009074-3A patent/BR0009074A/pt not_active IP Right Cessation
- 2000-03-10 PL PL350147A patent/PL200384B1/pl not_active IP Right Cessation
- 2000-03-10 CZ CZ20013341A patent/CZ301524B6/cs not_active IP Right Cessation
- 2000-03-10 EP EP00909351A patent/EP1161530B1/en not_active Expired - Lifetime
- 2000-03-10 PT PT00909351T patent/PT1161530E/pt unknown
- 2000-03-10 SI SI200030723T patent/SI1161530T1/xx unknown
- 2000-03-10 DK DK00909351T patent/DK1161530T3/da active
- 2000-03-10 WO PCT/EP2000/002117 patent/WO2000056885A1/en active Search and Examination
- 2000-03-10 ES ES00909351T patent/ES2240067T3/es not_active Expired - Lifetime
- 2000-03-10 MX MXPA01009363A patent/MXPA01009363A/es active IP Right Grant
- 2000-03-10 AT AT00909351T patent/ATE295883T1/de active
- 2000-03-10 DE DE60020220T patent/DE60020220T2/de not_active Expired - Lifetime
- 2000-03-10 CN CNB008052115A patent/CN1185344C/zh not_active Expired - Fee Related
- 2000-03-10 AU AU31662/00A patent/AU767172B2/en not_active Ceased
- 2000-03-14 MY MYPI20000991A patent/MY123371A/en unknown
- 2000-03-17 AR ARP000101192A patent/AR023099A1/es active IP Right Grant
- 2000-03-17 CO CO00019687A patent/CO5241328A1/es not_active Application Discontinuation
-
2001
- 2001-09-17 NO NO20014506A patent/NO330769B1/no not_active IP Right Cessation
-
2002
- 2002-09-16 HK HK02106777.4A patent/HK1045330B/zh not_active IP Right Cessation
-
2004
- 2004-05-17 US US10/846,668 patent/US6962801B2/en not_active Expired - Fee Related
-
2005
- 2005-06-16 US US11/153,433 patent/US7090986B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200102729T2 (tr) | Platelet yapışmasını bloke etme amaçlı protein | |
ES2306483T5 (es) | Prote�?na inhibidora de la ruta de señalización de wnt. | |
AR002024A1 (es) | Proteinas utiles para el tratamiento de la obesidad, composiciones farmaceuticas que incluyen dichas proteinas para tratamientos anti-obesidady procedimiento para prepararlas. | |
JP2010155859A (ja) | 生物活性ケラチンタンパク質 | |
DE69434538D1 (de) | Vaskularer endothelialer wachstumsfaktor 2 | |
NZ279963A (en) | Human tissue inhibitor of metalloproteinase-4 (timp-4) and dna (rna) encoding polypeptide which may be derived from atcc 75946 | |
WO1997015598A1 (en) | Novel peptide | |
CN1659184B (zh) | 活化凝血酶原的蛋白 | |
KR970701724A (ko) | 스타니어스 단백질인 스타니오칼신의 소체(Corpuscles of stannius protein, stanniocalcin) | |
AU630132B2 (en) | Anticoagulant peptides | |
KR100718589B1 (ko) | 세포 부착 및 퍼짐을 촉진하는 펩티드, 그의 단편 및 그의유도체 | |
MY109158A (en) | Modified platelet factor-4. | |
NO980300L (no) | Nye höymolekylære humane MP52 proteiner | |
Mao et al. | SM50 repeat-polypeptides self-assemble into discrete matrix subunits and promote appositional calcium carbonate crystal growth during sea urchin tooth biomineralization | |
TNSN95068A1 (fr) | Oligonucleotides pour inhiber le role des isoprenyl proteine transferases | |
BG105682A (en) | Bone stimulating factor | |
DE69712182D1 (de) | Peptide und ihre verwendung in der therapie von krankheiten des zöliakie-formenkreises | |
US6103691A (en) | Utilisation of angiogenin and/or α1 -microglobulin and/or complement factor D in order to inhibit the secretion of proteins | |
US5232912A (en) | Anticoagulant peptides | |
WO1997012036A3 (en) | Bone stimulating factor | |
KR950703993A (ko) | 치주 조직 질환 치료제(periodonal disease remedy) | |
PT789761E (pt) | Scf humano, uma respectiva variante de processamento, sua utilizacao farmaceutica | |
ATE417061T1 (de) | Scorpionpeptid als blutdrucksenkendes mittel | |
JPH0474132A (ja) | 歯根膜ならびに歯槽骨組織再生修復促進剤 | |
ECSP003383A (es) | Proteina para bloquear la adherencia plaquetaria |